JPWO2021129656A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021129656A5 JPWO2021129656A5 JP2022539175A JP2022539175A JPWO2021129656A5 JP WO2021129656 A5 JPWO2021129656 A5 JP WO2021129656A5 JP 2022539175 A JP2022539175 A JP 2022539175A JP 2022539175 A JP2022539175 A JP 2022539175A JP WO2021129656 A5 JPWO2021129656 A5 JP WO2021129656A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- fgfr2b
- antibody according
- fgfr1b
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/127903 | 2019-12-24 | ||
| CN2019127903 | 2019-12-24 | ||
| PCT/CN2020/138591 WO2021129656A1 (en) | 2019-12-24 | 2020-12-23 | Novel anti-fgfr2b antibodies |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023508173A JP2023508173A (ja) | 2023-03-01 |
| JPWO2021129656A5 true JPWO2021129656A5 (https=) | 2024-01-05 |
| JP2023508173A5 JP2023508173A5 (https=) | 2024-01-05 |
| JP7686000B2 JP7686000B2 (ja) | 2025-05-30 |
Family
ID=76573701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539175A Active JP7686000B2 (ja) | 2019-12-24 | 2020-12-23 | 新規抗ＦＧＦＲ２ｂ抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230052256A1 (https=) |
| EP (1) | EP4081539A4 (https=) |
| JP (1) | JP7686000B2 (https=) |
| KR (1) | KR20220119143A (https=) |
| CN (1) | CN114901687A (https=) |
| AR (1) | AR120884A1 (https=) |
| AU (1) | AU2020410863A1 (https=) |
| CA (1) | CA3160811A1 (https=) |
| MX (1) | MX2022007960A (https=) |
| TW (1) | TWI861325B (https=) |
| WO (1) | WO2021129656A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023243773A1 (en) * | 2022-03-28 | 2024-10-24 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Novel anti-fgfr2 antibodies. |
| CN117917435A (zh) * | 2022-10-21 | 2024-04-23 | 北京天广实生物技术股份有限公司 | 结合fgfr2b的抗体及其用途 |
| WO2024199362A1 (en) * | 2023-03-31 | 2024-10-03 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Novel anti-FGFR2 antibodies |
| CN118994393A (zh) * | 2023-05-19 | 2024-11-22 | 广东东阳光药业股份有限公司 | 一种抗fgfr2抗体及其应用 |
| WO2025146131A1 (en) * | 2024-01-05 | 2025-07-10 | Beigene, Ltd. | ANTI-FGFR2b ANTIBODIES, CONJUGATES AND METHODS OF USE |
| CN121319178A (zh) * | 2024-07-02 | 2026-01-13 | 安博泰克药业有限公司 | 特异性结合FGFR2b的抗体及其与药物的缀合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1717248A1 (en) * | 1997-06-04 | 2006-11-02 | Oxford Biomedica (UK) Limited | Tumor targeted vector |
| CA2518371A1 (en) * | 2003-03-14 | 2004-09-30 | Wyeth | Antibodies against human il-21 receptor and uses therefor |
| AU2003271174A1 (en) * | 2003-10-10 | 2005-04-27 | Chugai Seiyaku Kabushiki Kaisha | Double specific antibodies substituting for functional protein |
| WO2005037235A2 (en) * | 2003-10-16 | 2005-04-28 | Imclone Systems Incorporated | Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| CA2572289A1 (en) * | 2004-06-30 | 2006-08-17 | Centocor, Inc. | Anti-mcp-1 antibodies, compositions, methods and uses |
| EP2046384A4 (en) * | 2006-06-15 | 2009-12-02 | Fibron Ltd | ANTIBODIES BLOCKING FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATION AND METHODS OF USING THE SAME |
| PL2365828T3 (pl) * | 2008-11-07 | 2015-04-30 | Galaxy Biotech Llc | Przeciwciała monoklonalne swoiste dla receptora 2 czynnika wzrostu fibroblastów |
| RU2014109038A (ru) * | 2011-08-23 | 2015-09-27 | Рош Гликарт Аг | Антитела к хондроитинсульфат протеогликану меланомы |
| AR088941A1 (es) * | 2011-11-23 | 2014-07-16 | Bayer Ip Gmbh | Anticuerpos anti-fgfr2 y sus usos |
| AU2012351685A1 (en) * | 2011-12-14 | 2014-07-03 | Seattle Genetics, Inc. | FGFR antibody drug conjugates (ADCs) and the use thereof |
| PH12021552742A1 (en) * | 2013-08-01 | 2022-05-23 | Five Prime Therapeutics Inc | Afucosylated anti-fgfr2iiib antibodies |
| CA2961439A1 (en) * | 2014-11-05 | 2016-05-12 | Genentech, Inc. | Anti-fgfr2/3 antibodies and methods using same |
| US20170145103A1 (en) * | 2015-11-23 | 2017-05-25 | Five Prime Therapeutics, Inc. | Predicting response to cancer treatment with fgfr2 inhibitors |
| DK3380522T5 (da) * | 2015-11-25 | 2024-09-30 | Visterra Inc | Antistofmolekyler til april og anvendelser deraf |
| WO2018095932A1 (en) * | 2016-11-22 | 2018-05-31 | Merck Patent Gmbh | Monoclonal antibody directed to fgfr1 |
| JP7265476B2 (ja) * | 2016-11-22 | 2023-04-26 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｆｇｆｒ１を対象とするモノクローナル抗体 |
| CA3160810A1 (en) * | 2019-12-24 | 2021-07-01 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Novel anti-fgfr2b antibodies |
| MX2022007961A (es) * | 2019-12-24 | 2022-07-12 | Dizal Jiangsu Pharmaceutical Co Ltd | Nuevos anticuerpos anti-fgfr2b. |
-
2020
- 2020-12-23 US US17/788,730 patent/US20230052256A1/en active Pending
- 2020-12-23 CN CN202080089840.3A patent/CN114901687A/zh active Pending
- 2020-12-23 MX MX2022007960A patent/MX2022007960A/es unknown
- 2020-12-23 KR KR1020227025531A patent/KR20220119143A/ko active Pending
- 2020-12-23 CA CA3160811A patent/CA3160811A1/en active Pending
- 2020-12-23 WO PCT/CN2020/138591 patent/WO2021129656A1/en not_active Ceased
- 2020-12-23 AR ARP200103629A patent/AR120884A1/es unknown
- 2020-12-23 AU AU2020410863A patent/AU2020410863A1/en active Pending
- 2020-12-23 JP JP2022539175A patent/JP7686000B2/ja active Active
- 2020-12-23 EP EP20907461.6A patent/EP4081539A4/en active Pending
- 2020-12-24 TW TW109145974A patent/TWI861325B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115052892A (zh) | 抗ccr8单克隆抗体及其用途 | |
| RU2728568C2 (ru) | Композиция для лечения рака, экспрессирующего igf-1r | |
| JP7820383B2 (ja) | グリピカン－３およびｔ細胞受容体を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド | |
| CN114040925B (zh) | 抗SIRPα单克隆抗体及其用途 | |
| CN108290931A (zh) | 对pd-l1具有亲和力的新的多肽 | |
| IL273389B1 (en) | New anti-CD19 antibodies | |
| CA2959671C (en) | Anti-ck8 antibodies for use in the treatment of cancers | |
| WO2025061181A1 (en) | Anti-cdh17 antibodies and uses thereof | |
| JPWO2021129672A5 (https=) | ||
| JPWO2021129655A5 (https=) | ||
| JP7827737B2 (ja) | Ｖｅｇｆａ結合分子 | |
| JPWO2021129656A5 (https=) | ||
| JP2025520692A (ja) | 抗ｓｌｃ３４ａ２モノクローナル抗体およびその使用 | |
| JPWO2022042719A5 (https=) | ||
| CN120271715A (zh) | 抗体及其药物偶联物和用途 | |
| HK40080157A (en) | Anti-gprc5d monoclonal antibodies and uses thereof | |
| CN116761887A (zh) | 靶向SIRPα和PD-L1的双特异性抗体 | |
| WO2025117871A1 (en) | Bispecific tetravalent antibody targeting her2 and her3 | |
| CN120379695A (zh) | 使用Multabody治疗化疗抗性肿瘤 | |
| CN118994393A (zh) | 一种抗fgfr2抗体及其应用 | |
| HK40069799B (en) | ANTI-SIRPα MONOCLONAL ANTIBODIES AND USES THEREOF | |
| CN121362226A (zh) | 抗体-药物偶联物及其用途 | |
| HK40080160A (en) | Anti-ccr8 monoclonal antibodies and uses thereof | |
| CN116355099A (zh) | 重组抗人ox40和pd-l1双特异抗体及应用 | |
| CN116964094A (zh) | 针对cd55的新型抗体及其用途 |